P. Laterre

P. Laterre, B. François, 2015, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Pharmacological inhibition of tissue factor.

P. Laterre, X. Wittebole, C. Collienne, 2006, Seminars in thrombosis and hemostasis.

Nangibotide in patients with septic shock: a Phase 2a randomized controlled clinical trial

F. Vandenhende, A. Olivier, J. Mira, 2020, Intensive Care Medicine.

Pharmacokinetic profiles of intravenous versus subcutaneous administration of low molecular weight heparin for thromboprophylaxis in critically ill patients: A randomized controlled trial.

P. Laterre, S. Eeckhoudt, X. Wittebole, 2022, Journal of critical care.

NETosis and Nucleosome Biomarkers in Septic Shock and Critical COVID-19 Patients: An Observational Study

C. Beauloye, S. Horman, P. Laterre, 2022, Biomolecules.

C-spine rule for radiography in trauma patients

J. Helterbrand, J. Vincent, P. Ferdinande, 2002 .

CURB-65, PSI, and APACHE II to Assess Mortality Risk in Patients With Severe Sepsis and Community Acquired Pneumonia in PROWESS

C. Feldman, P. Laterre, G. Richards, 2011, Journal of intensive care medicine.

Hepatorenal syndrome: the clinical impact of vasoactive therapy

I. Colle, P. Laterre, 2018, Expert review of gastroenterology & hepatology.

H. Goossens, H. Jafri, J. Pugin, 2022, Journal of clinical microbiology.

Steroid use in PROWESS severe sepsis patients treated with drotrecogin alfa (activated)

P. Laterre, H. Levy, Rebecca L. Qualy, 2005, Critical care.

Surgical mask on top of high-flow nasal cannula improves oxygenation in critically ill COVID-19 patients with hypoxemic respiratory failure

P. Laterre, A. Robert, X. Wittebole, 2020, Annals of Intensive Care.

A clinical evaluation committee assessment of recombinant human tissue factor pathway inhibitor (tifacogin) in patients with severe community-acquired pneumonia

R. Wunderink, S. Opal, E. Abraham, 2009, Critical care.

Beyond antibiotics in severe community-acquired pneumonia: the role and rationale for tissue factor pathway inhibition

P. Laterre, 2008, Critical care.

Furthering our understanding of sepsis and septic shock

P. Hantson, P. Laterre, C. Watremez, 2016 .

The SAATELLITE and EVADE Clinical Studies Within the COMBACTE Consortium: A Public-Private Collaborative Effort in Designing and Performing Clinical Trials for Novel Antibacterial Drugs to Prevent Nosocomial Pneumonia.

M. Bonten, H. Jafri, A. Torres, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Incidence and prognosis of intraabdominal hypertension in a mixed population of critically ill patients: A multiple-center epidemiological study*

Manu L. N. G. Malbrain, Paolo Pelosi, Luciano Gattinoni, 2005, Critical care medicine.

Adult liver transplantation and abnormalities of splanchnic veins: experience in 53 patients

P. Laterre, J. Lerut, P. Goffette, 1997, Transplant international : official journal of the European Society for Organ Transplantation.

Immunomodulatory Treatment of Severe Acute Pancreatitis

P. Laterre, T. Dugernier, M. Reynaert, 2002 .

ADDRESS (ADministration of DRotrecogin alfa [activated] in Early stage Severe Sepsis) long-term follow-up: One-year safety and efficacy evaluation*

E. Abraham, P. Laterre, F. Booth, 2007, Critical care medicine.

Extensive pallidal and white matter injury following cocaine overdose

P. Hantson, P. Laterre, T. Duprez, 2007, Intensive Care Medicine.

The causal relationship between O2:K7:H6 extra-intestinal pathogenic Escherichia coli (ExPEC) and native valve endocarditis: a case report

P. Hantson, P. Laterre, N. Boisen, 2021, BMC Infectious Diseases.

Targeting toll-like receptors 4 intracellular domain to prevent ischemic liver disease: an innovative approach or just a futuristic dream?.

S. Opal, P. Laterre, X. Wittebole, 2014, Critical care medicine.

Energy expenditure in the critically ill performing early physical therapy

P. Laterre, J. Roeseler, D. Castanares-Zapatero, 2014, Intensive Care Medicine.

Nephrogenic Diabetes Insipidus following an Off-Label Administration of Sevoflurane for Prolonged Sedation in a COVID-19 Patient and Possible Influence on Aquaporin-2 Renal Expression

P. Hantson, P. Laterre, J. Morelle, 2022, Case reports in anesthesiology.

Re-use of a liver allograft; an exceptional opportunity to enlarge the organ donor pool

O. Ciccarelli, P. Laterre, J. Lerut, 2003, Transplant international : official journal of the European Society for Organ Transplantation.

Circulating dipeptidyl peptidase 3 and bio-adrenomedullin levels are associated with impaired outcomes in critically ill COVID-19 patients: a prospective international multicentre study

A. Mebazaa, B. Plaud, P. Pickkers, 2022, ERJ Open Research.

Clinical trials in severe sepsis with drotrecogin alfa (activated)

P. Laterre, 2007, Critical care.

Passive leg cycling and electrical stimulation cannot preserve strength in sepsis

P. Laterre, D. Castanares-Zapatero, C. Hickmann, 2019, Critical Care.

Traumatic injuries: imaging and intervention in post-traumatic complications (delayed intervention)

P. Laterre, P. Goffette, 2002 .

UNIVERSITE DE LAUSANNE - FACULTE DE BIOLOGIE ET DE MEDECINE Département des centres interdisciplinaires et logistique médicale Service de Médecine intensive adulte et centre des brûlés Neurally Adjusted Ventilatory Assist improves patient-ventilator interaction

Emilie Bialais, Jean Roeseler, Pierre-François Laterre, 2014 .

Co-infections in COVID-19 critically ill and antibiotic management: a prospective cohort analysis

P. Laterre, X. Wittebole, A. Scohy, 2020, Critical Care.

A phase II study of human allogeneic liver-derived progenitor cell therapy for acute-on-chronic liver failure and acute decompensation

F. Nevens, S. Michel, P. Laterre, 2021, JHEP reports : innovation in hepatology.

Association between in-ICU red blood cells transfusion and 1-year mortality in ICU survivors

A. Mebazaa, S. Jaber, J. Josse, 2022, Critical Care.

p55 Tumor necrosis factor receptor fusion protein in the treatment of patients with severe sepsis and septic shock. A randomized controlled multicenter trial. Ro 45-2081 Study Group.

H. Bruining, T. Butler, K. Kudsk, 1997, JAMA.

COVID-19 infection associated with autoimmune hemolytic anemia

P. Hantson, P. Laterre, S. Bailly, 2020, Annals of Hematology.

COVID-19 Infection Associated With Auto-immune Hemolytic Anemia

P. Hantson, P. Laterre, S. Bailly, 2020 .

Management of patients with severe sepsis, treated by drotrecogin alfa (activated).

P. Laterre, D. Heiselman, 2002, American journal of surgery.

Case Report: TAVI in a Patient with Single Coronary Artery and Bicuspid Valve

P. Laterre, Z. Yousif, M. Bertin, 2020, Case reports in cardiology.

Alkaline phosphatase for treatment of sepsis-induced acute kidney injury: a prospective randomized double-blind placebo-controlled trial

J. Vincent, P. Jorens, J. G. van der Hoeven, 2012, Critical Care.

Association between in-ICU red blood cells transfusion and 1-year mortality in ICU survivors

A. Mebazaa, S. Jaber, J. Josse, 2022, Critical Care.

Population pharmacokinetics of four β-lactams in critically ill septic patients comedicated with amikacin.

F. Taccone, P. Laterre, P. Jacqmin, 2012, Clinical biochemistry.

Chylous ascites: diagnosis, causes and treatment.

P. Laterre, T. Dugernier, M. Reynaert, 2000, Acta gastro-enterologica Belgica.

Closed-loop ventilation mode (IntelliVent®-ASV) in intensive care unit: a randomized trial.

P. Hantson, M. Wysocki, Johannes Meyer, 2016, Minerva anestesiologica.

Preoperative frailty screening, assessment and management

P. Laterre, M. Cappe, M. Dechamps, 2022, Current opinion in anaesthesiology.

Drotrecogin Alfa (activated) Improves In-hospital and 90-day Survival in Patients With Severe Sepsis and Community-acquired Pneumoni

R. Wunderink, S. Yende, P. Laterre, 2003 .

Increased Angiotensin-Converting Enzyme 2 and Loss of Alveolar Type II Cells in COVID-19–related Acute Respiratory Distress Syndrome

P. Laterre, C. Bouzin, C. Pilette, 2021, American journal of respiratory and critical care medicine.

VO2/DO2 relationship III

J. Vincent, R. Fernandez, A. Artigas, 1992, Intensive Care Medicine.

The challenge of ventilator-associated pneumonia diagnosis in COVID-19 patients

P. Laterre, B. François, J. Chastre, 2020, Critical Care.

sTREM-1 is a specific biomarker of TREM-1 pathway activation

A. Mebazaa, T. van der Poll, P. Laterre, 2021, Cellular & Molecular Immunology.

Liver transplantation and haemophilia A.

P. Laterre, M. Reynaert, J. Lerut, 1995, Journal of hepatology.

A Large Retrospective Assessment of Voriconazole Exposure in Patients Treated with Extracorporeal Membrane Oxygenation

H. Lyster, F. Taccone, P. Laterre, 2021, Microorganisms.

Insufficient β-lactam concentrations in the early phase of severe sepsis and septic shock

Frédérique Jacobs, Fabio Silvio Taccone, Pierre Wallemacq, 2010, Critical care.

Revisiting the loading dose of amikacin for patients with severe sepsis and septic shock

J. Vincent, F. Taccone, D. De Backer, 2010, Critical care.

Artificial Liver Support

O. Ciccarelli, P. Hantson, P. Laterre, 2014 .

Serum uric acid, disease severity and outcomes in COVID-19

M. Jadoul, P. Hantson, C. Beauloye, 2021, Critical Care.

Guidelines for management of intra- abdominal infections

J. Constantin, P. Laterre, B. Misset, 2015, Anaesthesia, critical care & pain medicine.

Prevalence of intra-abdominal hypertension in critically ill patients: a multicentre epidemiological study

P. Singer, P. Pelosi, M. Ranieri, 2004, Intensive Care Medicine.

Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials

Mohammad Sohel Rahman, Henrik Nielsen, M. Shankar-Hari, 2021, BMC Infectious Diseases.

A multicenter randomized trial to assess the efficacy of CONvalescent plasma therapy in patients with Invasive COVID-19 and acute respiratory failure treated with mechanical ventilation: the CONFIDENT trial protocol

G. Meyfroidt, M. Moutschen, D. Grimaldi, 2020, BMC Pulmonary Medicine.

Rapid and Specific Molecular Identification of Methicillin-Resistant Staphylococcus aureus in Endotracheal Aspirates from Mechanically Ventilated Patients

P. Vannuffel, J. Gala, P. Laterre, 1998, Journal of Clinical Microbiology.

Pharmacokinetics of a loading dose of amikacin in septic patients undergoing continuous renal replacement therapy.

J. Vincent, F. Taccone, D. De Backer, 2011, International journal of antimicrobial agents.

The SOFA score—development, utility and challenges of accurate assessment in clinical trials

M. Levy, P. Laterre, B. François, 2019, Critical Care.

The effects of etomidate on adrenal responsiveness and mortality in patients with septic shock

C. Sprung, M. Singer, D. Annane, 2009, Intensive Care Medicine.

International integrated database for the evaluation of severe sepsis and drotrecogin alfa (activated) therapy: 28-day survival and safety.

M. Levy, J. Vincent, E. Abraham, 2007, Journal of critical care.

The efficacy and safety of recombinant human activated protein C for the treatment of patients with severe sepsis (vol 28, pg 48, 2000)

Gary Garber, Jay Steingrub, Pierre-François Laterre, 2001 .

Randomized Trial of Micafungin for the Prevention of Invasive Fungal Infection in High-Risk Liver Transplant Recipients

V. E. Zagaynov, I. Popescu, J. Decruyenaere, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

SARS-CoV-2 causes a specific dysfunction of the kidney proximal tubule

B. Gerber, E. Coche, M. Jadoul, 2020, Kidney International.

Effect of recombinant surfactant protein C-based surfactant on the acute respiratory distress syndrome.

W. Seeger, J. Johannigman, P. Laterre, 2004, New England Journal of Medicine.

Antimicrobials: a global alliance for optimizing their rational use in intra-abdominal infections (AGORA)

M. Boermeester, Yonghong Xiao, Soumitra R. Eachempati, 2016, World Journal of Emergency Surgery.

NAVA enhances tidal volume and diaphragmatic electro-myographic activity matching: a Range90 analysis of supply and demand

Katherine T. Moorhead, Yeong Shiong Chiew, Thomas Desaive, 2013, Journal of Clinical Monitoring and Computing.

Liver transplantation and HBsAg-positive postnecrotic cirrhosis: adequate immunoprophylaxis and delta virus co-infection as the significant determinants of long-term prognosis.

O. Ciccarelli, J. Jamart, P. Laterre, 1999, Journal of hepatology.

Hepatitis C viral infection and adult liver transplantation: a difficult clinical problem.

O. Ciccarelli, P. Laterre, J. Lerut, 1994, Transplantation proceedings.

Early Antibiotic Treatment for Severe Acute Necrotizing Pancreatitis: A Randomized, Double-Blind, Placebo-Controlled Study

S. Ashley, E. P. Dellinger, P. Barie, 2007, Annals of surgery.

Cavocaval adult liver transplantation and retransplantation without venovenous bypass and without portocaval shunting: a prospective feasibility study in adult liver transplantation

O. Ciccarelli, P. Laterre, M. de Kock, 2003, Transplantation.

Breakthrough in cardiac arrest: reports from the 4th Paris International Conference

P. Kudenchuk, Steven Laureys, P. Hantson, 2015, Annals of Intensive Care.

Fatal type B lactic acidosis in a patient with end-stage liver disease related to homozygous sickle cell disease

P. Hantson, P. Laterre, E. Sokal, 2019, Annals of Hematology.

The Loss of Metabolic Control on Alcohol Drinking in Heavy Drinking Alcohol-Dependent Subjects

Patrice D Cani, A. Neyrinck, N. Delzenne, 2012, PloS one.

Upper gastrointestinal tract bleeding management: Belgian guidelines for adults and children.

I. Colle, O. Moine, A. Wilmer, 2011, Acta gastro-enterologica Belgica.

Hydrocortisone in septic shock: too much, too little, too soon?

P. Laterre, F. Thys, 2005, Critical care medicine.

Soluble ST2 plasma concentrations predict mortality in severe sepsis

T. van der Poll, P. Laterre, M. Tanck, 2010, Intensive Care Medicine.

Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trial.

J. Vincent, D. Angus, R. Schein, 2013, JAMA.

Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism [ISRCTN74215569]

Alain Cariou, James A Russell, J. Dhainaut, 2004, Critical care.

Drotrecogin alfa (activated) administration across clinically important subgroups of patients with severe sepsis

J. Helterbrand, G. Bernard, J. Vincent, 2003, Critical care medicine.

Pharmacokinetics and safety of panobacumab: specific adjunctive immunotherapy in critical patients with nosocomial Pseudomonas aeruginosa O11 pneumonia.

M. Rudolf, Q. Lu, J. Rouby, 2011, The Journal of antimicrobial chemotherapy.

Pharmacokinetics and safety of panobacumab : specific adjunctive immunotherapy in critical patients with nosocomial Pseudomonas aeruginosa O 11 pneumonia

M. Rudolf, Q. Lu, J. Rouby, 2011 .

Tracking the foreign body, a rare cause of hepatic abscess

P. Laterre, C. Dangoisse, 2014, BMC Gastroenterology.

p55 Tumor Necrosis Factor Receptor Fusion Protein in the Treatment of Patients With Severe Sepsis and Septic Shock: A Randomized Controlled Multicenter Trial

H. Bruining, T. Butler, K. Kudsk, 1997 .

Efficacy and safety of recombinant human activated protein C for severe sepsis

J. Helterbrand, J. Barkun, G. Bernard, 2003 .

Compartmentalization of the Protease-antiprotease Balance in Early Severe Acute Pancreatitis

P. Laterre, G. Deby-dupont, M. Reynaert, 2005, Pancreas.

Intravenous omeprazole in critically ill patients: A randomized, crossover study comparing 40 with 80 mg plus 8 mg/hour on intragastric pH

P. Laterre, Y. Horsmans, 2001, Critical care medicine.

Ornipressin (Por 8): An Efficient Alternative to Counteract Hypotension During Combined General/Epidural Anesthesia

P. Laterre, P. Lavand'homme, M. D. De Kock, 2000, Anesthesia and analgesia.

Severe acute pancreatitis: pathophysiologic mechanisms underlying pancreatic necrosis and remote organ damage.

P. Laterre, T. Dugernier, M. Reynaert, 1996, Acta gastro-enterologica Belgica.

Epidural analgesia in critically ill patients with acute pancreatitis: the multicentre randomised controlled EPIPAN study protocol

S. Jaber, V. Sapin, A. Sossou, 2017, BMJ Open.

Cavocaval liver transplantation without venovenous bypass and without temporary portocaval shunting: the ideal technique for adult liver grafting?

O. Ciccarelli, M. Kock, P. Laterre, 1997, Transplant international : official journal of the European Society for Organ Transplantation.

Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial.

C. Sprung, R. Postier, C. Doig, 2003, JAMA.

Drotrecogin alfa (activated) in the treatment of severe sepsis patients with multiple-organ dysfunction: data from the PROWESS trial

J. Bakker, G. Bernard, J. Vincent, 2003, Intensive Care Medicine.

Tacrolimus Monotherapy in Liver Transplantation: One-Year Results of a Prospective, Randomized, Double-Blind, Placebo-Controlled Study

Olga Ciccarelli, Giuseppe Orlando, Pierre Wallemacq, 2008, Annals of surgery.

Compartmentalization of the Inflammatory Response during Acute Pancreatitis Correlation with Local and Systemic Complications Sampling Protocol and Cytokine Assays

J. Pugin, P. Laterre, D. Latinne, 2022 .

Improving the management of severe acute pancreatitis: The new guidelines from the French Society of Anaesthesia and Intensive Care Medicine.

P. Laterre, C. Collienne, 2022, Anaesthesia, critical care & pain medicine.

Current Surgical Management of Acute Pancreatitis

P. Laterre, T. Dugernier, J. Dewaele, 2006, Acta chirurgica Belgica.

Correction: Epidural analgesia in critically ill patients with acute pancreatitis: the multicentre randomised controlled EPIPAN study protocol

S. Jaber, V. Sapin, A. Sossou, 2018, BMJ Open.

Postoperative care of the pancreas transplant patient

P. Laterre, M. Mourad, X. Wittebole, 2020 .

Adrenal function in sepsis: The retrospective Corticus cohort study

C. Sprung, M. Singer, D. Annane, 2007, Critical care medicine.

SPECT-CT Comparison of Lung Deposition using a System combining a Vibrating-mesh Nebulizer with a Valved Holding Chamber and a Conventional Jet Nebulizer: a Randomized Cross-over Study

Michel Hesse, François Jamar, Gregory Reychler, 2017, Pharmaceutical Research.

Ascites fluid in severe acute pancreatitis: from pathophysiology to therapy.

P. Laterre, T. Dugernier, M. Reynaert, 2000, Acta gastro-enterologica Belgica.

The Effects of Intraoperative Intravenous Clonidine on Gastric Intramucosal PCO2

P. Laterre, M. D. De Kock, P. Laterre, 1998, Anesthesia and analgesia.

Electrical Vagus Nerve Stimulation and Nicotine Effects in Peritonitis-Induced Acute Lung Injury in Rats

P. Laterre, X. Wittebole, V. Collet, 2011, Inflammation.

Early multi-system organ failure associated with acute pancreatitis: a plea for a conservative therapeutic strategy.

P. Laterre, T. Dugernier, M. Reynaert, 2003, Acta gastro-enterologica Belgica.

French Intensive Care Society, International congress – Réanimation 2016

Paul P. Tallon, Stéphane Huot, B. Souweine, 2016, Annals of Intensive Care.

Immunotherapies for COVID-19: lessons learned from sepsis

Bruno Francois, Guillaume Monneret, Lyle L Moldawer, 2020, The Lancet Respiratory Medicine.

Temocillin plasma and pancreatic tissue concentrations in a critically ill patient with septic shock

P. Laterre, P. Tulkens, A. Capron, 2019, The Journal of antimicrobial chemotherapy.

Association of Interleukin 7 Immunotherapy With Lymphocyte Counts Among Patients With Severe Coronavirus Disease 2019 (COVID-19)

R. Hotchkiss, P. Hantson, P. Laterre, 2020, JAMA network open.

Carnitine Deficiency after Long-Term Continuous Renal Replacement Therapy

P. Hantson, P. Laterre, C. Collienne, 2022, Case reports in critical care.

Anticoagulant therapy in acute lung injury

J. Dhainaut, P. Laterre, X. Wittebole, 2003, Critical care medicine.

A PILOT-CONTROLLED STUDY OF A POLYMYXIN B-IMMOBILIZED HEMOPERFUSION CARTRIDGE IN PATIENTS WITH SEVERE SEPSIS SECONDARY TO INTRA-ABDOMINAL INFECTION

J. Vincent, H. Bruining, S. Brett, 2005, Shock.

Fulminant Hepatic Failure in the Course of an Outpatient Anesthetic Procedure: Sevoflurane among Other High-Risk Factors

P. Hantson, P. Laterre, P. Hoet, 2020, Case reports in anesthesiology.

Recurrent seizure and sustained encephalopathy associated with dimethylsulfoxide-preserved stem cell infusion

G. Cosnard, P. Hantson, L. Michaux, 2005, Leukemia & lymphoma.

Recurrent postinfantile syncytial giant cell hepatitis after orthotopic liver transplantation

O. Ciccarelli, C. Galant, P. Laterre, 1998, Transplant international : official journal of the European Society for Organ Transplantation.

Autoimmune hemolytic anemia in COVID-19 patients, the « transmissible » direct Coombs test

V. Deneys, P. Laterre, L. Belkhir, 2021 .

Delayed colopericardial fistula and pyopneumopericardium

F. Jouret, P. Laterre, D. Castanares-Zapatero, 2010, Intensive Care Medicine.

Empirical models for dosage optimization of four beta-lactams in critically ill septic patients based on therapeutic drug monitoring of amikacin.

J. Vincent, F. Taccone, P. Laterre, 2010, Clinical biochemistry.

UvA-DARE ( Digital Academic Repository ) Soluble ST 2 plasma concentrations predict mortality in severe sepsis

P. Laterre, M. Tanck, X. Wittebole, 2010 .

LY315920NA/S-5920, a selective inhibitor of group IIA secretory phospholipase A2, fails to improve clinical outcome for patients with severe sepsis*

A. Dmitrienko, E. Abraham, P. Laterre, 2005, Critical care medicine.

Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death.

R. Rossaint, E. Abraham, P. Laterre, 2005, The New England journal of medicine.

Pseudomonas aeruginosa serotypes in nosocomial pneumonia: prevalence and clinical outcomes

M. Rudolf, Q. Lu, J. Rouby, 2014, Critical Care.

Prognostic performance of endothelial biomarkers to early predict clinical deterioration of patients with suspected bacterial infection and sepsis admitted to the emergency department

M. Sebbane, L. Jacquin, P. Laterre, 2020, Annals of Intensive Care.

Lenercept (p55 tumor necrosis factor receptor fusion protein) in severe sepsis and early septic shock: A randomized, double-blind, placebo-controlled, multicenter phase III trial with 1,342 patients

T. Butler, K. Kudsk, W. Lesslauer, 2001, Critical care medicine.

Population Pharmacokinetic Modeling and Optimal Sampling Strategy for Bayesian Estimation of Amikacin Exposure in Critically Ill Septic Patients

Joakim Nyberg, Frédérique Jacobs, Flora T Musuamba, 2010, Therapeutic drug monitoring.

Acute kidney injury in the ICU: from injury to recovery: reports from the 5th Paris International Conference

R. Bellomo, C. Ronco, P. Asfar, 2017, Annals of Intensive Care.

Adult liver transplantation and steroid-azathioprine withdrawal in cyclosporine (Sandimmun)-based immunosuppression – 5 year results of a prospective study

O. Ciccarelli, C. Sempoux, P. Laterre, 2001, Transplant international : official journal of the European Society for Organ Transplantation.

New Agents in Development for Sepsis: Any Reason for Hope?

P. Laterre, P. Vignon, B. François, 2020, Drugs.

Clinical Impact of MALDI-TOF MS Identification and Rapid Susceptibility Testing on Adequate Antimicrobial Treatment in Sepsis with Positive Blood Cultures

Michel Delmée, Pierre-François Laterre, M. Delmée, 2016, PloS one.

Heart donation after fatal acetaminophen poisoning.

P. Hantson, M. Vekemans, P. Vanormelingen, 1997, Journal of toxicology. Clinical toxicology.

Binding of temocillin to plasma proteins in vitro and in vivo: the importance of plasma protein levels in different populations and of co-medications.

M. Zeitlinger, P. Laterre, P. Tulkens, 2022, The Journal of antimicrobial chemotherapy.

Re‐use of a liver allograft; an exceptional opportunity to enlarge the organ donor pool

O. Ciccarelli, P. Laterre, J. Lerut, 2003 .

Lipopolysaccharide-binding protein serum levels in patients with severe sepsis due to gram-positive and fungal infections.

P. Laterre, X. Wittebole, L. Blairon, 2003, The Journal of infectious diseases.

Neutrophil-to-Lymphocyte Ratio Predicts Death in Acute-on-Chronic Liver Failure Patients Admitted to the Intensive Care Unit: A Retrospective Cohort Study

P. Forget, P. Laterre, X. Wittebole, 2017, Shock.

Liver function abnormalities, clinical profile, and outcome in acute decompensated heart failure.

A. Cohen-Solal, A. Mebazaa, N. Deye, 2013, European heart journal.

S100A12 and Soluble Receptor for Advanced Glycation End Products Levels During Human Severe Sepsis

M. Boermeester, T. van der Poll, T. Vogl, 2013, Shock.

Inflammation-Induced Coagulopathy Substantially Differs Between COVID-19 and Septic Shock: A Prospective Observational Study

L. Gatto, L. Bertrand, C. Beauloye, 2022, Frontiers in Medicine.

Changes in cardiac arrest patients’ temperature management after the 2013 “TTM” trial: results from an international survey

B. de Jonghe, A. Kimmoun, N. Deye, 2016, Annals of Intensive Care.

36th International Symposium on Intensive Care and Emergency Medicine

R. Pizov, E. Mancini, G. Van den Berghe, 2016, Critical Care.

The clinical evaluation committee in a large multicenter phase 3 trial of drotrecogin alfa (activated) in patients with severe sepsis (PROWESS): Role, methodology, and results*

R. Schein, J. Dhainaut, D. Maki, 2003, Critical care medicine.

Teamwork enables high level of early mobilization in critically ill patients

P. Laterre, J. Roeseler, X. Wittebole, 2016, Annals of Intensive Care.

Designing phase 3 sepsis trials: application of learned experiences from critical care trials in acute heart failure

G. Van den Berghe, A. Mebazaa, J. Marshall, 2016, Journal of Intensive Care.

Proceedings of Réanimation 2017, the French Intensive Care Society International Congress

K. Tarte, G. Le Roux, D. Boels, 2017, Annals of Intensive Care.

Impact of Very Early Physical Therapy During Septic Shock on Skeletal Muscle: A Randomized Controlled Trial

L. Deldicque, M. Francaux, P. Laterre, 2018, Critical care medicine.

Evaluating the Efficacy and Safety of Two Doses of the Polyclonal Anti-Tumor Necrosis Factor-&agr; Fragment Antibody AZD9773 in Adult Patients With Severe Sepsis and/or Septic Shock: Randomized, Double-Blind, Placebo-Controlled Phase IIb Study*

M. Levy, G. Bernard, J. Vincent, 2014, Critical care medicine.

Objective: This trial compared the efficacy/safety of two IV doses of AZD9773, a polyclonal antibody to tumor necrosis factor-α, in adult patients with severe sepsis/septic shock

M. Levy, G. Bernard, J. Vincent, 2014 .

Hemodynamic and metabolic effects of rapid correction of hypophosphatemia in patients with septic shock.

P. Laterre, L. Nace, P. Bollaert, 1995, Chest.

Electrocardiographic changes after head trauma.

B. Gerber, P. Hantson, C. Brohet, 2005, Journal of Electrocardiology.

Takotsubo Syndrome Associated with Isolated Hyponatremia: Case Report

P. Hantson, P. Laterre, C. Lefebvre, 2021 .

Sources of variability on the estimate of treatment effect in the PROWESS trial: Implications for the design and conduct of future studies in severe sepsis*

G. Bernard, J. Vincent, J. Dhainaut, 2004, Critical care medicine.

Severe community-acquired pneumonia as a cause of severe sepsis: Data from the PROWESS study*

R. Wunderink, J. Dhainaut, D. Maki, 2005, Critical care medicine.

Rationale and protocol for the efficacy, safety and tolerability of nangibotide in patients with septic shock (ASTONISH) phase IIb randomised controlled trial

A. Olivier, P. Laterre, B. François, 2021, BMJ Open.

Ct-proAVP is Not a Good Predictor of Vasopressor Need in Septic Shock

P. Laterre, X. Wittebole, S. Laribi, 2015, Shock.

Safety and tolerability of non-neutralizing adrenomedullin antibody adrecizumab (HAM8101) in septic shock patients: the AdrenOSS-2 phase 2a biomarker-guided trial

A. Mebazaa, A. Bergmann, P. Jorens, 2021, Intensive Care Medicine.

Monitoring circulating dipeptidyl peptidase 3 (DPP3) predicts improvement of organ failure and survival in sepsis: a prospective observational multinational study

Jacob, Jaschinski, A. Mebazaa, 2021, Critical Care.

Circulating adrenomedullin estimates survival and reversibility of organ failure in sepsis: the prospective observational multinational Adrenomedullin and Outcome in Sepsis and Septic Shock-1 (AdrenOSS-1) study

A. Mebazaa, M. Antonelli, J. Struck, 2018, Critical Care.

Proenkephalin A 119-159 (Penkid) Is an Early Biomarker of Septic Acute Kidney Injury: The Kidney in Sepsis and Septic Shock (Kid-SSS) Study

A. Mebazaa, M. Antonelli, J. Struck, 2018, Kidney international reports.

Determinants of long-term outcome in ICU survivors: results from the FROG-ICU study

A. Mebazaa, E. Vicaut, M. Singer, 2018, Critical Care.

Heart failure / cardiomyopathy Liver function abnormalities , clinical profile , and outcome in acute decompensated heart failure

A. Cohen-Solal, A. Mebazaa, N. Deye, 2013 .

Pattern of Paracetamol Poisoning: Influence on Outcome and Complications

P. Hantson, P. Laterre, D. Castanares-Zapatero, 2018, Toxics.

Hospital mortality and resource use in subgroups of the Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis (PROWESS) trial *

G. Clermont, D. Angus, J. Dhainaut, 2004, Critical care medicine.

The effect of drotrecogin alfa (activated) on long-term survival after severe sepsis *

G. Bernard, D. Angus, L. Weissfeld, 2004, Critical care medicine.

Still puzzled by additional data from the PROWESS study - Reply

P. Laterre, H. Levy, 2005 .

Study protocol of a randomised, double-blind, placebo-controlled, two-arm parallel-group, multi-centre phase 3 pivotal trial to investigate the efficacy and safety of recombinant human alkaline phosphatase for treatment of patients with sepsis-associated acute kidney injury

R. Bellomo, J. Kellum, C. Doig, 2023, BMJ Open.

Severe community acquired pneumonia update: mortality, mechanisms and medical intervention

P. Laterre, 2008, Critical care.

Immobilization-Related Hypercalcemia in a COVID-19 Patient With Prolonged Intensive Care Unit Stay

P. Hantson, P. Laterre, C. Collienne, 2021, American journal of physical medicine & rehabilitation.

ResearchRevisiting the loading dose of amikacin for patients with severe sepsis and septic shock

J. Vincent, F. Taccone, D. Backer, 2015 .

A randomized placebo-controlled phase II study of a Pseudomonas vaccine in ventilated ICU patients

J. Vincent, J. Rello, T. Welte, 2017, Critical Care.

One-Year Prognosis of Kidney Injury at Discharge From the ICU: A Multicenter Observational Study.

A. Mebazaa, S. Jaber, Q. Lu, 2019, Critical care medicine.

Recombinant human platelet-activating factor acetylhydrolase for treatment of severe sepsis: Results of a phase III, multicenter, randomized, double-blind, placebo-controlled, clinical trial*

S. Opal, S. Lowry, W. McGee, 2004, Critical care medicine.

ResearchInsufficient β-lactam concentrations in the early phase of severe sepsis and septic shock

J. Vincent, F. Taccone, D. Backer, 2015 .

Researchβ-lactam concentrations in the early phase of severe sepsis and septic shock

J. Vincent, F. Taccone, D. Backer, 2010 .

A REGISTRY OF PATIENTS TREATED WITH DROTRECOGIN ALFA (ACTIVATED) IN BELGIAN INTENSIVE CARE UNITS - AN OBSERVATIONAL STUDY

J. Raemaekers, J. Decruyenaere, P. Laterre, 2008, Acta clinica Belgica.

Multinational, observational study of procalcitonin in ICU patients with pneumonia requiring mechanical ventilation: a multicenter observational study

J. Marshall, J. Vincent, D. Angus, 2011, Critical care.

Significance of pathologic oxygen supply dependency in critically ill patients: Comparison between measured and calculated methods

P. Laterre, G. Hanique, T. Dugernier, 2006, Intensive Care Medicine.

Bioactive Adrenomedullin, Organ Support Therapies, and Survival in the Critically Ill: Results from the French and European Outcome Registry in ICU Study.

A. Mebazaa, J. Struck, A. Bergmann, 2019, Critical care medicine.

Clinical review: Drotrecogin alfa (activated) as adjunctive therapy for severe sepsis – practical aspects at the bedside and patient identification

P. Laterre, X. Wittebole, 2003, Critical care.

Assessment of panobacumab as adjunctive immunotherapy for the treatment of nosocomial Pseudomonas aeruginosa pneumonia

Q. Lu, J. Rouby, J. Revelly, 2014, European Journal of Clinical Microbiology & Infectious Diseases.

Predictors of clinicians' underuse of daily sedation interruption and sedation scales

N. Speybroeck, B. Sneyers, P. Laterre, 2017, Journal of critical care.

What stops us from following sedation recommendations in intensive care units? A multicentric qualitative study.

M. Perreault, B. Sneyers, P. Laterre, 2014, Journal of critical care.

Optimizing β-lactams treatment in critically-ill patients using pharmacokinetics/pharmacodynamics targets: are first conventional doses effective?

F. Taccone, P. Laterre, P. Tulkens, 2017, Expert review of anti-infective therapy.

Clinical characteristics and short-term prognosis of in-patients with diabetes and COVID-19: A retrospective study from an academic center in Belgium

P. Laterre, J. Yombi, J. Thissen, 2020, Diabetes & Metabolic Syndrome: Clinical Research & Reviews.

Oxidative stress-induced endothelial dysfunction and decreased vascular nitric oxide in COVID-19 patients

P. Hantson, J. Balligand, C. Beauloye, 2022, eBioMedicine.

Acute Effects of Sitting Out of Bed and Exercise on Lung Aeration and Oxygenation in Critically Ill Subjects

P. Laterre, J. Roeseler, X. Wittebole, 2020, Respiratory Care.

Erratum: Antimicrobials: A global alliance for optimizing their rational use in intra-abdominal infections (AGORA). [World J Emerg Surg. 11, (2016) (33)] DOI: 10.1186/s13017-016-0089-y

M. Boermeester, Yonghong Xiao, J. Vincent, 2017 .

COVID-19: an ‘extraterrestrial’ disease?

P. Laterre, B. Rentier, V. Ridde, 2021, International Journal of Infectious Diseases.

Prolonged unconsciousness in a patient on automated peritoneal dialysis.

P. Hantson, P. Laterre, P. Wallemacq, 2006, European journal of emergency medicine : official journal of the European Society for Emergency Medicine.

The IASIS, INHALE and VAPORISE trials. Reasons for a triple failure: study design, aminoglycosides dosing and technique of nebulisation.

J. Rouby, J. Pugin, O. Mimoz, 2020, Anaesthesia, critical care & pain medicine.

Ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria: understanding nebulization of aminoglycosides and colistin

J. Rello, T. Welte, J. Rouby, 2020, Intensive Care Medicine.

Impact of angiotensin-converting enzyme inhibitors or receptor blockers on post-ICU discharge outcome in patients with acute kidney injury

A. Mebazaa, S. Jaber, Q. Lu, 2018, Intensive Care Medicine.

Dexamethasone Modulates the Cytokine Response but Not COVID-19-Induced Coagulopathy in Critically Ill

L. Bertrand, C. Beauloye, A. Ginion, 2023, International journal of molecular sciences.

A phase Ib/IIa, randomised, double-blind, multicentre trial to assess the safety and efficacy of expanded Cx611 allogeneic adipose-derived stem cells (eASCs) for the treatment of patients with community-acquired bacterial pneumonia admitted to the intensive care unit

T. van der Poll, P. Laterre, E. Lombardo, 2020, BMC Pulmonary Medicine.

Intravenous Lipid Emulsion in a Case of Trazodone Overdose.

V. Haufroid, P. Hantson, P. Laterre, 2022, The Primary Care Companion For CNS Disorders.

Should we continue to test soluble thrombomodulin, or other systemic anticoagulants, as a life-saving therapy for sepsis-induced coagulopathy?

M. Levy, S. Opal, P. Laterre, 2019, Anaesthesia, critical care & pain medicine.

When Is a Critically Ill Cirrhotic Patient Too Sick to Transplant? Development of Consensus Criteria by a Multidisciplinary Panel of 35 International Experts.

F. Tacke, S. Jaber, K. Olthoff, 2020, Transplantation.

[Neurological Disorders Revealing Behcet Disease - 4 Clinical Case-reports]

P. Laterre, C. Laterre, C. Sindic, 1990 .

[Neurological involvement as manifestation of Behçet's disease. 4 clinical case reports].

P. Laterre, C. Laterre, C. Sindic, 1990, Acta Neurologica Belgica.

Effect of Selepressin vs Placebo on Ventilator- and Vasopressor-Free Days in Patients With Septic Shock: The SEPSIS-ACT Randomized Clinical Trial.

S. Opal, D. Yealy, J. Decruyenaere, 2019, JAMA.

Rationale and Design of an Adaptive Phase 2b/3 Clinical Trial of Selepressin for Adults in Septic Shock. Selepressin Evaluation Programme for Sepsis-induced Shock-Adaptive Clinical Trial.

D. Angus, D. Yealy, R. Lewis, 2018, Annals of the American Thoracic Society.

The effect of renal replacement therapy and antibiotic dose on antibiotic concentrations in critically ill patients: Data from the multinational SMARRT Study.

R. Bellomo, J. Rello, K. Klein, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Nearly fatal metabolic acidosis: septic or toxic?

P. Hantson, P. Laterre, V. Huberlant, 2010, European journal of emergency medicine : official journal of the European Society for Emergency Medicine.

Three‐dimensional critical care transesophageal echocardiography: A bedside tool in the diagnosis and management of shock

P. Laterre, F. Forêt, J. Higny, 2021, Clinical case reports.

Prognostic factors of acute mesenteric ischemia in ICU patients

P. Hantson, P. Laterre, D. Castanares-Zapatero, 2019, BMC Gastroenterology.

Temocillin (6 g daily) in critically ill patients: continuous infusion versus three times daily administration.

P. Laterre, P. Tulkens, J. Mouton, 2015, The Journal of antimicrobial chemotherapy.

Ruptured hydatid cyst in a patient with shock.

P. Laterre, D. Castanares-Zapatero, 2009, Hepatobiliary & pancreatic diseases international : HBPD INT.

Systemic and local high mobility group box 1 concentrations during severe infection

M. Boermeester, T. van der Poll, A. Ishizaka, 2007, Critical care medicine.

Therapeutic dose of acetaminophen may induce fulminant hepatitis in the presence of risk factors: a report of two cases.

P. Forget, P. Laterre, X. Wittebole, 2009, British journal of anaesthesia.

Skeletonizing En Bloc Esophagectomy for Cancer

D. Glineur, P. Laterre, M. Reynaert, 2001, Annals of surgery.

Efficacy and safety of suvratoxumab for prevention of Staphylococcus aureus ventilator-associated pneumonia (SAATELLITE): a multicentre, randomised, double-blind, placebo-controlled, parallel-group, phase 2 pilot trial.

H. Goossens, M. Bonten, H. Jafri, 2021, Lancet. Infectious Diseases (Print).

Refractory shock during the anesthetic and surgical management of an intrahepatic tumor arising from the adrenal cortex: A case report

P. Hantson, P. Laterre, D. Castanares-Zapatero, 2020, International journal of surgery case reports.

SAFETY PROFILE OF DROTRECOGIN ALFA (ACTIVATED) IN SEVERE SEPSIS PATIENTS FROM THE INDEPTH INTEGRATED DATABASE: 615

J. Dhainaut, P. Laterre, D. Nelson, 2004 .

Erratum to: 36th International Symposium on Intensive Care and Emergency Medicine

R. Pizov, E. Mancini, G. Van den Berghe, 2016, Critical Care.

Evaluation of the efficacy and safety of TREM-1 inhibition with nangibotide in patients with COVID-19 receiving respiratory support: the ESSENTIAL randomised, double-blind trial

P. Asfar, J. Mira, C. Vinsonneau, 2023, eClinicalMedicine.

Prospective evaluation of the efficacy, safety, and optimal biomarker enrichment strategy for nangibotide, a TREM-1 inhibitor, in patients with septic shock (ASTONISH): a double-blind, randomised, controlled, phase 2b trial.

V. Jalkanen, V. Pettilä, J. Mira, 2023, The Lancet. Respiratory medicine.

What is the optimal loading dose of broad-spectrum β-lactam antibiotics in septic patients? Results from a PK simulation modelling.

F. Taccone, P. Laterre, F. Jacobs, 2020, International journal of antimicrobial agents.

Thoracic epidural analgesia in intensive care unit patients with acute pancreatitis: the EPIPAN multicenter randomized controlled trial

S. Jaber, D. Verzilli, T. Rimmele, 2023, Critical Care.

Profile of liver cholestatic biomarkers following prolonged ketamine administration in patients with COVID-19

P. Hantson, P. Laterre, P. Baldin, 2023, BMC Anesthesiology.

Regional citrate anticoagulation and influence of recirculation on ionized calcium levels in the circuit

P. Hantson, P. Laterre, E. Danse, 2019, Journal of Artificial Organs.

Toll-like Receptor 4 Modulation as a Strategy to Treat Sepsis

P. Laterre, X. Wittebole, D. Castanares-Zapatero, 2010, Mediators of inflammation.

Efficacy and safety of recombinant human activated protein C for severe sepsis.

J Ean, ngel, J Effrey, 2001, The New England journal of medicine.

A double-blind, placebo-controlled, randomised, multicentre, proof-of-concept and dose-finding phase II clinical trial to investigate the safety, tolerability and efficacy of adrecizumab in patients with septic shock and elevated adrenomedullin concentration (AdrenOSS-2)

A. Mebazaa, P. Pickkers, P. Laterre, 2019, BMJ Open.

90-DAY FOLLOW-UP OF PATIENTS TREATED WITH DROTRECOGIN ALFA (ACTIVATED) FOR SEVERE SEPSIS: A BELGIAN OPEN LABEL STUDY

J. Raemaekers, J. Decruyenaere, D. De Backer, 2009, Acta clinica Belgica.

Adjunctive therapies for severe sepsis.

P. Laterre, X. Wittebole, D. Castanares-Zapatero, 2008, International journal of antimicrobial agents.

Erratum to: Antimicrobials: a global alliance for optimizing their rational use in intra-abdominal infections (AGORA)

M. Boermeester, Yonghong Xiao, Soumitra R. Eachempati, 2017, World Journal of Emergency Surgery.

A randomized placebo-controlled phase II study of a Pseudomonas vaccine in ventilated ICU patients

J. Vincent, J. Rello, T. Welte, 2017 .

Effects of enrichment strategies on outcome of adrecizumab treatment in septic shock: Post-hoc analyses of the phase II adrenomedullin and outcome in septic shock 2 trial

A. Mebazaa, J. Struck, A. Bergmann, 2022, Frontiers in Medicine.

Added value of serial bio-adrenomedullin measurement in addition to lactate for the prognosis of septic patients admitted to ICU

A. Mebazaa, M. Antonelli, T. Beeker, 2020, Critical Care.

Triad of obstructive uropathy, cholestasis, and pneumomediastinum associated with chronic ketamine abuse: a case report

P. Hantson, P. Laterre, Jean-Baptiste Mesland, 2021, Toxicology Communications.

Soluble ST2 plasma concentrations predict mortality in severe sepsis

T. van der Poll, P. Laterre, M. Tanck, 2010, Intensive Care Medicine.

Increased hepatocytic mitotic activity as a diagnostic marker of acute arsenic intoxication. A report of two cases.

P. Hantson, P. Laterre, M. Reynaert, 1996, Journal of hepatology.

Point-of-care versus diagnostic ultrasound in the intensive care unit

P. Laterre, L. Annet, E. Danse, 2013 .

Elevation of alkaline phosphatase and long-term drug therapy for cystic fibrosis

V. Haufroid, P. Hantson, P. Laterre, 2022, European Journal of Clinical Pharmacology.

Comparison of an entirely automated ventilation mode, Intellivent-ASV, with conventional ventilation in ARDS patients: a 48-hour study

P. Hantson, M. Wysocki, D. Novotni, 2013 .

Neutrophil-to-lymphocyte ratio is associated with mortality in critically-ill cirrhotic patients

P. Forget, P. Laterre, X. Wittebole, 2015, Intensive Care Medicine Experimental.

M. Levy, G. Bernard, J. Vincent, 2014, Critical Care Medicine.

Compartmentalization of the inflammatory response during acute pancreatitis: correlation with local and systemic complications.

J. Pugin, P. Laterre, D. Latinne, 2003, American journal of respiratory and critical care medicine.

Cost-effectiveness of drotrecogin alfa (activated) in the treatment of severe sepsis*

G. Clermont, G. Bernard, J. Vincent, 2003, Critical care medicine.

Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism [ISRCTN74215569]

J. Dhainaut, A. Cariou, P. Laterre, 2004, Critical care.

Multinational, observational study of procalcitonin in ICU patients with pneumonia requiring mechanical ventilation: a multicenter observational study

J. Marshall, J. Vincent, D. Angus, 2011, Critical care.

90-DAY FOLLOW-UP OF PATIENTS TREATED WITH DROTRECOGIN ALFA (ACTIVATED) (DAA) FOR SEVERE SEPSIS: A BELGIAN OPEN LABEL STUDY.: 37

J. Raemaekers, J. Decruyenaere, D. De Backer, 2005 .

Platypnea–orthodeoxia syndrome in a postoperative patient: a case report

P. Hantson, P. Laterre, B. Ghaye, 2021, Journal of Medical Case Reports.

Neurally adjusted ventilatory assist improves patient–ventilator interaction

P. Laterre, J. Roeseler, D. Tassaux, 2011, Intensive Care Medicine.

The safety and efficacy of stem cells for the treatment of severe community-acquired bacterial pneumonia: A randomized clinical trial

J. Caballero, P. Laterre, X. Wittebole, 2024, Journal of Critical Care.

S100A12 and Soluble Receptor for Advanced Glycation End Products Levels During Human Severe Sepsis

M. Boermeester, T. van der Poll, T. Vogl, 2013, Shock.

Aerosol Delivery with Two Nebulizers Through High-Flow Nasal Cannula: A Randomized Cross-Over Single-Photon Emission Computed Tomography-Computed Tomography Study.

F. Jamar, P. Laterre, J. Roeseler, 2017, Journal of aerosol medicine and pulmonary drug delivery.

Progress in medical management of intra-abdominal infection

P. Laterre, 2008, Current opinion in infectious diseases.

Antimicrobial Therapy for Intra-Abdominal Infections: Guidelines from the Infectious Disease Advisory Board (IDAB)

M. Delmée, P. Laterre, A. Vergison, 2006, Acta chirurgica Belgica.

Selepressin for Patients With Septic Shock-Reply.

D. Angus, R. Lewis, P. Laterre, 2020, Journal of the American Medical Association (JAMA).

Dispatcher assisted telephone cardiopulmonary resuscitation using a french-language compression-ventilation pediatric protocol

A. Zwinderman, J. Kellum, M. Tucci, 2016 .

Convalescent Plasma for Covid-19–Induced ARDS in Mechanically Ventilated Patients

G. Meyfroidt, P. Laterre, V. Compernolle, 2023, The New England journal of medicine.

Soluble ST2 plasma concentrations predict mortality in severe sepsis

T. van der Poll, P. Laterre, M. Tanck, 2010, Intensive Care Medicine.